Novartis drug Tasigna approved by FDA to treat children with rare form of leukemia Pharmaceutical Investing
Reata Announces Positive Top-Line Data for Treatment of PH-ILD With Bardoxolone Methyl From the Phase 2 Lariat Trial Pharmaceutical Investing
Auris Medical Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results Pharmaceutical Investing
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with CellBridge Genetics Investing
Prothena Announces Global Neuroscience Research & Development Collaboration with Celgene Biotech Investing
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
